Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA chief vows fast delivery of new biosimilar rules
Fierce Biotech
Tuesday, February 22, 2011 - 11:18am
tags:
FDA, biosimilars, Peggy Hamburg
Suits Against Vaccine Makers Curbed by U.S. Supreme Court
Bloomberg
Tuesday, February 22, 2011 - 11:17am
tags:
vaccines, Supreme Court, lawsuits, Pfizer, Wyeth
Bayer chief looks to pump up pharma unit
Fierce Pharma
Tuesday, February 22, 2011 - 10:50am
tags:
Bayer, Marijn Dekkers, Pharma CEOs
Just How Likely Is It That Diabetes Drugmaker Amylin Could Go Bankrupt?
BNET Pharma
Tuesday, February 22, 2011 - 10:48am
tags:
diabetes, Amylin, Byetta
Takeda yanks established drug on efficacy questions
Fierce Pharma
Tuesday, February 22, 2011 - 10:47am
tags:
Takeda, Dasen
Which Sales Reps Rank Highest With Oncologists?
Pharmalot
Tuesday, February 22, 2011 - 10:36am
tags:
drug reps, oncologists, Roche, Genentech, Novartis
Gilead to acquire Calistoga Pharmaceuticals for $375M
Bizjournals.com
Tuesday, February 22, 2011 - 10:25am
tags:
Gilead Sciences, Calistoga Pharmaceuticals, M&A
Dynavax says universal flu vaccine working well in tests
Bizjournals.com
Tuesday, February 22, 2011 - 10:22am
tags:
Dynavax, Flu, vaccines
Human Genome: Betting on Benlysta Approval
Seeking Alpha
Tuesday, February 22, 2011 - 9:40am
tags:
Benlysta, FDA, Human Genome Sciences, lupus
Exelixis seen narrowing Q4 loss, increasing revenue
Bizjournals.com
Tuesday, February 22, 2011 - 9:28am
tags:
earnings, Exelixis
Forest Laboratories to Buy Clinical Data for $1.2 Billion
Bloomberg
Tuesday, February 22, 2011 - 9:24am
tags:
M&A, Forest Labs, Clinical Data
Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
Yahoo
Tuesday, February 22, 2011 - 9:23am
tags:
JNJ, Crucell, M&A
Ranbaxy Got 30% Market Share for Generic Aricept in December
Bloomberg
Tuesday, February 22, 2011 - 9:18am
tags:
Ranbaxy, generics, Aricept, Eisai, Alzheimer's disease
Kansas recovers $5.8M in Medicaid fraud settlements
Bizjournals.com
Tuesday, February 22, 2011 - 9:16am
tags:
Kansas, Medicaid, settlements, fraud
Celgene: Biotech Baron or Barren Biotech?
Seeking Alpha
Monday, February 21, 2011 - 11:05am
tags:
Celgene
Apricus Bioscience: A Plethora of Pipeline Products With Market Moving Potential
Seeking Alpha
Monday, February 21, 2011 - 11:04am
tags:
Apricus Biosciences, Vitaros, pipelines
China Biotech Week in Review: China Encourages Private Entities to Invest in Healthcare
Seeking Alpha
Sunday, February 20, 2011 - 12:31pm
tags:
China
Johnson & Johnson's Growth? Mainly in Recalls
Seeking Alpha
Sunday, February 20, 2011 - 12:21pm
tags:
JNJ, recalls
Genzyme's Drug Trials Show Positive Results on the Heels of Sanofi Buyout Announcement
Seeking Alpha
Sunday, February 20, 2011 - 12:20pm
tags:
Genzyme, Sanofi, eliglustat tartrate, Gaucher disease
HIPAA/HITECH regulations are coming: what do pharmaceutical companies need to know? (part 1 of 5)
Lexology
Sunday, February 20, 2011 - 12:18pm
tags:
HIPPA, HITECH

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.